DalsnaFinance › IPOs › CytoMed Therapeutics › IPO

CytoMed Therapeutics Ltd IPO

Completed

CytoMed Therapeutics Ltd completed its initial public offering on NASDAQ on April 14, 2023, pricing at $4.00 a share.

Ticker	GDTC
Exchange	NASDAQ
Status	Completed
Listing date	April 14, 2023
Offering price	$4.00
Shares offered	2,412,369
Total raised	$10M

The offering

CytoMed Therapeutics Ltd sold 2,412,369 shares at $4.00 each on NASDAQ. Multiplied out, that is $9.6 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $10 million total recorded for the deal.

Company coverage

CytoMed Therapeutics Ltd — quote, profile and latest news →

Other recent IPOs

First Breach, Inc. · August 12, 2026
Advasa Holdings, Inc. · August 11, 2026
Latigo Biotherapeutics, Inc. · August 4, 2026
BOA Acquisition Corp. II · August 3, 2026
Obsidian Therapeutics, Inc. · August 3, 2026
Attovia Therapeutics, Inc. · July 29, 2026
Game Your Game Inc. · July 27, 2026
Scribe Therapeutics, Inc. · July 21, 2026

Source: SEC EDGAR filings for CytoMed Therapeutics Ltd. This page is general information, not investment advice.